ALRPD.PA Rapid Nutrition PLC

Consumer Defensive Pharmaceuticals Euronext Paris
1.77 EUR
Close of Nov 8, 2026
1.75 15.00
Market cap
EUR 843K
P/E
-
P/B
0.24x
ROE
-117.4%
Dividend yield
-
Fundamental score
1.3/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is ALRPD.PA undervalued?

Graham number

The Graham number of Rapid Nutrition PLC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Rapid Nutrition PLC fundamental analysis

4 of 11 checks passed

ROE 2/2

ROE surpassing expectations (588.06%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

ROA 0/2

The stock's ROA (-402.2%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

PBV 1/2

The stock's PBV ratio (1.66x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

DER 0/2

The company has a high debt to equity ratio (330%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

Revenue Growth 0/2

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

Net Profit Growth 0/2

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

Assets Growth 0/2

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

Graham Number 1/1

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

Dividend Growth 0/2

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

Dividend 0/2

The company's lack of dividends in the past three years may concern investors seeking regular income.

Buffet Intrinsic Value 1/1

The company's stock presents an enticing opportunity as it appears undervalued (0) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Rapid Nutrition PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Rapid Nutrition PLC

Rapid Nutrition PLC, a natural healthcare company, develops and distributes science-based health and wellness products worldwide. It offers natural and organic ingredients designed to support weight loss under the System LS brand name; herbal medicine for symptoms of sore throat, colds, and flu, as well as added Ashwagandha and Andrographis for strong immunity boost for travelers under the Azurene brand name. It also provides products under the third-party brands. Rapid Nutr…

Full company profile